Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE

被引:17
|
作者
Branche, Brandee L. [1 ]
Howard, Lauren E. [1 ,2 ]
Moreira, Daniel M. [3 ]
Roehrborn, Claus [4 ]
Castro-Santamaria, Ramiro [5 ]
Andriole, Gerald L. [6 ]
Hopp, Martin L.
Freedland, Stephen J. [1 ,7 ]
机构
[1] Duke Univ, Sch Med, Durham Vet Affairs Med Ctr, Surg Sect, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA
[3] Univ Illinois, Chicago, IL USA
[4] Univ Texas Southwestern, Med Ctr, Dallas, TX USA
[5] GlaxoSmithKline Inc, Metab Pathways & Cardiovasc R&D Unit, King Of Prussia, PA USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Cedars Sinai Med Ctr, 8635 West 3rd St,Suite 1070W, Los Angeles, CA 90048 USA
来源
JOURNAL OF UROLOGY | 2018年 / 199卷 / 02期
基金
美国国家卫生研究院;
关键词
prostate; prostatic hyperplasia; lower urinary tract symptoms; sleep; patient reported outcome measures; PROSTATE-CANCER EVENTS; OBESITY; TRIAL; DUTASTERIDE; METABOLISM; NOCTURIA; SCALE; TIME; RISK; MEN;
D O I
10.1016/j.juro.2017.08.108
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Although lower urinary tract symptoms and sleep problems often develop together, to our knowledge it is unknown whether sleep disturbances are linked to lower urinary tract symptoms development and progression. As measured by the 6-item MOS-Sleep (Medical Outcomes Study Sleep Scale) survey we examined the relationship between sleep problems, and the development and progression of lower urinary tract symptoms in the REDUCE (Reduction by Dutasteride of Prostate Cancer Events) study. Materials and Methods: REDUCE was a randomized trial testing prostate cancer chemoprevention with dutasteride in men with prostate specific antigen 2.5 to 10 ng/ml and a negative biopsy. At baseline men completed MOS-Sleep and a scaled average was used to calculate the sleep score. Men were followed for 4 years and I-PSS (International Prostate Symptom Score) was completed at baseline and every 6 months. Asymptomatic men had I-PSS less than 8 while symptomatic men had I-PSS 8 or greater. In the placebo arm of 2,588 men not receiving a-blockers or 5a-reductase inhibitors at baseline we tested the association between sleep problems and lower urinary tract symptom development and progression using Cox models. Results: During followup lower urinary tract symptoms developed in 209 of 1,452 asymptomatic men (14%) and 580 of 1,136 (51%) with lower urinary tract symptoms demonstrated progression. On multivariable analysis higher sleep scores were suggestively associated with increased lower urinary tract symptoms in asymptomatic men (quartile 4 vs 1 HR 1.41, 95% CI 0.92-2.17, p = 0.12) and with lower urinary tract symptom progression in symptomatic men (per 10 points of sleep score HR 1.06, 95% CI 1.01-1.12, p = 0.029). Conclusions: Among men with lower urinary tract symptoms worse sleep scores were associated with the progression of lower urinary tract symptoms and among asymptomatic men worse sleep scores were suggestively associated with the development of lower urinary tract symptoms. If confirmed, these data suggest that sleep problems may precede such symptoms. Whether treating sleep problems would improve lower urinary tract symptoms requires further testing.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 50 条
  • [21] URINARY PHYTOESTROGENS ARE ASSOCIATED WITH LOWER URINARY TRACT SYMPTOMS IN WOMEN
    Kreydin, Evgeniy
    Barrisford, Glen
    Rodriguez, Dayron
    Santiago-Lastra, Yahir
    Sanchez, Alejandro
    Preston, Mark
    Keenan, Hillary
    Ko, Dicken
    JOURNAL OF UROLOGY, 2014, 191 (04): : E387 - E387
  • [22] Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population
    Rohrmann, Sabine
    Katzke, Verena
    Kaaks, Rudolf
    UROLOGY, 2016, 95 : 158 - 163
  • [23] Lower urinary tract symptoms are beyond lower urinary tract
    Wu, Ming-Ping
    GYNECOLOGY AND MINIMALLY INVASIVE THERAPY-GMIT, 2015, 4 (04): : 101 - 101
  • [24] Prostatic Fibrosis is Associated with Lower Urinary Tract Symptoms
    Ma, Jinjin
    Gharaee-Kermani, Mehrnaz
    Kunju, Lakshmi
    Hollingsworth, John M.
    Adler, Jeremy
    Arruda, Ellen M.
    Macoska, Jill A.
    JOURNAL OF UROLOGY, 2012, 188 (04): : 1375 - 1381
  • [25] Ketamine is associated with lower urinary tract signs and symptoms
    Pal, R.
    Balt, S.
    Erowid, E.
    Erowid, F.
    Baggott, M. J.
    Mendelson, J.
    Galloway, G. P.
    DRUG AND ALCOHOL DEPENDENCE, 2013, 132 (1-2) : 189 - 194
  • [26] Prevalence of conditions associated with lower urinary tract symptoms
    Gades, NM
    Jacobson, DJ
    Girman, CJ
    Roberts, RO
    Lieber, MM
    Jacobsen, SJ
    JOURNAL OF UROLOGY, 2004, 171 (04): : 404 - 404
  • [27] Does Peak Urine Flow Rate Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from REDUCE EDITORIAL COMMENT
    Welliver, Charles
    JOURNAL OF UROLOGY, 2017, 198 (03): : 655 - 656
  • [28] Reproductive History and Progression of Lower Urinary Tract Symptoms in Women: Results From a Population-based Cohort Study
    Maserejian, Nancy N.
    Curto, Teresa
    Hall, Susan A.
    Wittert, Gary
    McKinlay, John B.
    UROLOGY, 2014, 83 (04) : 788 - 794
  • [29] Lifestyle and Progression of Lower Urinary Tract Symptoms in German Men-Results From the EPIC-Heidelberg Cohort
    Rohrmann, Sabine
    Katzke, Verena A.
    Kaaks, Rudolf
    UROLOGY, 2018, 120 : 192 - 196
  • [30] Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study
    Inge I. Bouwman
    Marco H. Blanker
    Boris W. V. Schouten
    Arthur M. Bohnen
    Rien J. M. Nijman
    Wouter K. van der Heide
    J. L. H. Ruud Bosch
    World Journal of Urology, 2015, 33 : 669 - 676